- authorisedTherapeutic confirmatory (Phase III)
A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice-daily Delgocitinib Cream in Adult Participants with Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period
This study tests a new cream called delgocitinib for adults with lichen sclerosus, a chronic inflammatory skin condition. Researchers want to see if applying this cream twice daily reduces pain, itching, and skin changes over one year, and whether it is safe and works better than a dummy cream.
Italy · France · Spain - recruitingPHASE3
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
This study is testing a new cream called delgocitinib for adults with Lichen Sclerosus (LS), a skin condition. It aims to see how well and safely the cream works compared to a dummy cream. Researchers want to find the best dose and will study both women and men.
United States · Canada · United Kingdom - enrolling by invitation
Vaginal Ecosystem and Network in the United States Study
This study looks at the tiny living things inside the Vagina to understand how they affect common female health issues. By collecting a simple swab, researchers hope to improve how doctors diagnose and treat conditions like thrush and UTIs.
United States · Canada